U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06940531) titled 'Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis' on April 01.
Brief Summary: The CF-Tracker study is a community surveillance study, designed to understand the causes of exacerbations in people with cystic fibrosis (CF) (pwCF). These are episodes when pwCF become more unwell, typically characterised by increased cough, sputum, and breathlessness, and requiring prolonged courses of oral or intravenous antibiotics.
This observational study applies a two-tiered approach over 12 months. It will recruit 200 pwCF to Group A, and an additional 100 pwCF to Group B, which follows the same format but in...